LI
ABBV icon

Louisbourg Investments’s AbbVie ABBV Stock Holding History

Louisbourg Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Hold
1,395
– – 0.06% 110
2026
Q1 		$303K Hold
1,395
– – 0.06% 118
2025
Q4 		$319K Hold
1,395
– – 0.06% 113
2025
Q3 		$323K Hold
1,395
– – 0.07% 109
2025
Q2 		$259K Hold
1,395
– – 0.06% 112
2025
Q1 		$292K Sell
1,395
-734
-34% -$143K 0.08% 108
2024
Q4 		$378K Hold
2,129
– – 0.1% 107
2024
Q3 		$420K Buy
2,129
+734
+53% +$137K 0.11% 103
2024
Q2 		$239K Hold
1,395
– – 0.07% 104
2024
Q1 		$254K Sell
1,395
-532
-28% -$91.7K 0.07% 103
2023
Q4 		$299K Buy
+1,927
New +$281K 0.09% 101

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Louisbourg Investments's ABBV Position: Q2 2026 in Review

Louisbourg Investments held its AbbVie (ABBV) position steady in Q2 2026 at 1,395 shares worth $351K. The position accounts for 0.06% of the portfolio, ranked #110.

Louisbourg Investments first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $420K in Q3 2024. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Louisbourg Investments held 1,395 shares of AbbVie worth $351K as of Q2 2026.
  • Louisbourg Investments left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.06% of Louisbourg Investments's portfolio in Q2 2026, its #110 holding.
  • Louisbourg Investments first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Louisbourg Investments's AbbVie position peaked at $420K in Q3 2024.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Louisbourg Investments's 13F filing for Q2 2026, filed 23 Jul 2026.